CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Unregistered share sale · Other events
- 4 Grant or award Director acquired 24,193 shares (grant or award)
- 4 Planned sale Director sold 15,500 shares at $5.90 ($91,433)
- 4 Planned sale Director sold 20,000 shares at $6.09 ($121,886)
- 4 Planned sale Director sold 16,000 shares at $6.09 ($97,507)
- 4 Planned sale Director sold 15,000 shares at $6.09 ($91,422)
- 4 Grant or award Director acquired 24,193 shares (grant or award)
- 8-K Event Shareholder vote results
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale See Remarks sold 16,667 shares at $6.06 ($100,982)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale See Remarks sold 16,667 shares at $6.23 ($103,805)
- ARS Other Annual Report to Security Holders
Page 3 of 18 · 346 filings